Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Emerald Health Therapeutics Inc (OP:EMHTF)

N/A UNCHANGED
Last Price Updated: 3:42 PM EST, Nov 11, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Emerald Health Therapeutics Inc

Emerald Health Therapeutics and Skye Bioscience Close Plan of Arrangement
Vancouver, British Columbia--(Newsfile Corp. - November 10, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Announces Bridge Loan to Skye Bioscience and Provides Update on Merger
Vancouver, British Columbia--(Newsfile Corp. - October 18, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Skye Bioscience Stockholders Vote in Favor of Arrangement Agreement with Emerald Health Therapeutics, Inc.
San Diego, California--(Newsfile Corp. - September 30, 2022) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical... 
Via Newsfile
Topics Derivatives
Emerald Health Therapeutics, Inc. Reports 2022 Q2 Results
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or... 
Via Newsfile
Emerald Health Therapeutics Receives Court Approval of Plan of Arrangement with Skye Bioscience
Vancouver, British Columbia--(Newsfile Corp. - August 26, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company")... 
Via Newsfile
Emerald Health Therapeutics Shareholders Vote in Favour of Plan of Arrangement with Skye Bioscience
Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Regulatory Compliance
Emerald Health Therapeutics, Inc. Reports 2022 Q1 Results
Vancouver, British Columbia--(Newsfile Corp. - July 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics, Inc. Reports 2021 Year-End Results and Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - July 4, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Signs Arrangement Agreement with Skye Bioscience
Arrangement is expected to fund Skye's proprietary synthetic cannabinoid-derivative therapeutic initially targeting glaucoma for first Phase 2 clinical study planned to... 
Via Newsfile
Topics Derivatives
Emerald Health Therapeutics Sells Patents to FlowerPod
Vancouver, British Columbia--(Newsfile Corp. - January 11, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered... 
Via Newsfile
Topics Cannabis Intellectual Property
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
Vancouver, British Columbia--(Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
Vancouver, British Columbia--(Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and... 
Via Newsfile
Topics Cannabis Supply Chain
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Vancouver, British Columbia--(Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announces that... 
Via Newsfile
Topics Cannabis Intellectual Property
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Vancouver, British Columbia--(Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today... 
Via Newsfile
Topics Cannabis Supply Chain
Emerald Health Therapeutics Reports 2021 Second Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - August 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released... 
Via Newsfile
Topics Cannabis Intellectual Property Product Recall
Emerald Health Therapeutics to Host 2021 Second Quarter Financial Results Conference Call on Tuesday, August 31, 2021 at 10:30 AM ET
Vancouver, British Columbia--(Newsfile Corp. - August 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced that it... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Comments on Board Resignation
Vancouver, British Columbia--(Newsfile Corp. - August 11, 2021) - Further to its press release of August 6th, Emerald Health Therapeutics,... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Hires VP Sales & Marketing
Vancouver, British Columbia--(Newsfile Corp. - August 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed... 
Via Newsfile
Topics Cannabis Supply Chain
Emerald Health Therapeutics Executive Chairman Avtar Dhillon Resigns
Vancouver, British Columbia--(Newsfile Corp. - August 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") today announced... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Retains Listing Agent to Sell Previously-Closed Greater Vancouver Cannabis Cultivation Facility
Vancouver, British Columbia--(Newsfile Corp. - July 23, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has retained... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Launches Fuse(TM) Lifestyle Brand with Fast-Acting Cannabis-Infused Beverage
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has introduced... 
Via Newsfile
Topics Cannabis
Emerald Health Therapeutics Reports 2021 First Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 1, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released... 
Via Newsfile
Topics Cannabis Intellectual Property Supply Chain
Emerald Health Therapeutics Signs Letter of Intent for Product Co-Development Agreement with Prima Botanical Wellness Brand
Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") and The... 
Via Newsfile
Topics Cannabis Intellectual Property Supply Chain
Emerald Health Therapeutics Licenses New Proprietary Cannabis Dried Flower Format Patent for use in United States
Vancouver, British Columbia--(Newsfile Corp. - May 6, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has entered... 
Via Newsfile
Topics Cannabis Intellectual Property
Emerald Health Therapeutics Appoints Moe Jiwan as Chief Operating Officer
Vancouver, British Columbia--(Newsfile Corp. - May 4, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has appointed Mr.... 
Via Newsfile
Topics Cannabis Supply Chain
Emerald Health Therapeutics Reports 2020 Year-end and Fourth Quarter Financial Results and Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has released... 
Via Newsfile
Topics Cannabis Intellectual Property Supply Chain
Emerald Health Therapeutics Confirms Effective Listing Date on Canadian Securities Exchange
Vancouver, British Columbia--(Newsfile Corp. - April 23, 2021) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald" or "the... 
Via Newsfile
Topics Cannabis
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.